Voyager Therapeutics, Inc. (NASDAQ: VYGR) Stock Information | RedChip

Voyager Therapeutics, Inc. (NASDAQ: VYGR)


$6.7450
-0.0950 ( -1.39% ) 39.1K

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Market Data


Open


$6.7450

Previous close


$6.8400

Volume


39.1K

Market cap


$373.01M

Day range


$6.6510 - $7.0170

52 week range


$5.7100 - $11.7200

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 67 May 13, 2024
def Proxies and info statements 6 Apr 25, 2024
ars Annual reports 1 Apr 25, 2024
4 Insider transactions 1 Apr 03, 2024
4 Insider transactions 1 Apr 03, 2024
4 Insider transactions 1 Apr 03, 2024
8-k 8K-related 14 Apr 02, 2024
4 Insider transactions 1 Mar 26, 2024
3 Insider transactions 2 Mar 26, 2024
8-k 8K-related 15 Mar 13, 2024

Latest News